QUARTERLY PROFIT
-
Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates
The self-care segment - which includes cough and cold medicine such as Tylenol and Benadryl - recorded $1.70 billion in net sales, up 3.5% year-on-year and above the average analyst estimate of $1.56 billion, according to LSEG data.
-
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
-
Teleflex beats quarterly profit estimates on healthy demand for medical devices
-
Cencora misses revenue estimates on weight-loss drug shortage
-
HCA beats first-quarter profit estimates on higher patient admissions
-
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
-
Abbott beats quarterly profit estimates on strong medical device sales
-
India's Cipla beats estimates with 11% rise in quarterly profit
Advertisement
Advertisement